1. 15LBA High tumoral IFNγ mRNA, PD-L1 protein, and combined IFNγ mRNA/PD-L1 protein expression associates with response to durvalumab (anti-PD-L1) monotherapy in NSCLC patients. (September 2015) Authors: Higgs, B.W.; Robbins, P.B.; Blake-Haskins, J.A.; Zhu, W.; Morehouse, C.; Brohawn, P.Z.; Rebelatto, M.C.; Yao, Y.; Jin, X.; Shi, L.; Ranade, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A plasma-based assay for assessment of tumour mutational burden in patients with metastatic non-small cell lung cancer in the first-line treatment setting: Results from the MYSTIC study. (March 2019) Authors: Si, H.; Kuziora, M.; Helman, E.; Quinn, K.; Brohawn, P.Z.; Raja, R.; Ranade, K.; Higgs, B.W. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1212 Analytical validation of an interferon-inducible gene expression kit as a potential diagnostic test for anifrolumab. (12th June 2018) Authors: Brohawn, P.K.; Higgs, B.W.; Patel, S.; Moody, A.; Cooper, P.; Ranade, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Abstracts from the 4th ImmunoTherapy of Cancer Conference: Prague, Czech Republic. 20–22 March 2017. (20th March 2017) Authors: Ženka, J.; Caisová, V.; Uher, O.; Nedbalová, P.; Kvardová, K.; Masáková, K.; Krejčová, G.; Paďouková, L.; Jochmanová, I.; Wolf, K. I.; Chmelař, J.; Kopecký, J.; Loumagne, L.; Mestadier, J.; D'agostino, S.; Rohaut, A.; Ruffin, Y.; Croize, V.; Lemaître, O.; Sidhu, S. S. Journal: Journal for immunotherapy of cancer Issue: Volume 5(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Past, present, and future for biologic intervention in atopic dermatitis. Issue 8 (20th May 2015) Authors: Howell, M. D.; Parker, M. L.; Mustelin, T.; Ranade, K. Journal: Allergy Issue: Volume 70:Issue 8(2015:Aug.) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0004 Genomic signatures characterize leukocyte infiltration in myositis muscles. (23rd January 2014) Authors: Zhu, W.; Streicher, K.; Shen, N.; Higgs, B.W.; Morehouse, C.; Greenlees, L.; Ranade, K.; Richman, L.; Fiorentino, D.; Jallal, B.; Greenberg, S.A.; Yao, Y. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0005 Investigating the Plasma Cell Signature in Autoimmune Disease. (23rd January 2014) Authors: Streicher, K.; Morehouse, C.; Groves, C.; Rajan, B.; Pilataxi, F.; Lehmann, K.; Brohawn, P. Z.; Higgs, B. W.; McKeever, K.; Greenberg, S. A.; Fiorentino, D.; Richman, L.; Jallal, B.; Herbst, R.; Yao, Y.; Ranade, K. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗